Earlier detection.
Continuous insight.
More precise care.
Novelna develops protein-based diagnostics, advanced biosensors, and AI-enabled clinical tools to detect disease earlier, follow biological changes, and support more precise treatment decisions.
Proteomics
Our scientific foundation
remains protein-based.
Novelna’s diagnostic work starts with broad protein measurements and the identification of patterns associated with disease.
Our blood- and urine-based programs use proteomic profiling and machine learning to investigate focused panels for diagnostic applications. Published plasma and urine studies provide the foundation for continuing research and validation.
Platform
From discovery
to clinical development.
We are extending a protein-based discovery and validation foundation into three complementary development paths, without replacing the diagnostic portfolio that established it.
Pipelines and Programs
Our established diagnostic portfolio, expanded by new programs in wearable molecular monitoring and precision critical care.
Our established diagnostic portfolio, expanded by new programs in wearable molecular monitoring and precision critical care.
Connect with Novelna to explore clinical research, technology development, or strategic collaboration.